Alex Hoyle

2.4k total citations
13 papers, 146 citations indexed

About

Alex Hoyle is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alex Hoyle has authored 13 papers receiving a total of 146 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alex Hoyle's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Alex Hoyle is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Alex Hoyle collaborates with scholars based in United Kingdom, Switzerland and United States. Alex Hoyle's co-authors include Noel W. Clarke, Matthew R. Sydes, Nicholas D. James, Adnan Ali, Malcolm D. Mason, Adrian Cook, Mahesh Parmar, Gerhardt Attard, Chris Brawley and David P. Dearnaley and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and JAMA Oncology.

In The Last Decade

Alex Hoyle

13 papers receiving 145 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alex Hoyle United Kingdom	6	127	66	36	27	14	13	146
J. Calvert United Kingdom	3	75 0.6×	42 0.6×	19 0.5×	21 0.8×	9 0.6×	5	93
Fredrik Laestadius Sweden	2	121 1.0×	39 0.6×	38 1.1×	38 1.4×	11 0.8×	3	137
Robin Millman United Kingdom	2	91 0.7×	27 0.4×	31 0.9×	16 0.6×	16 1.1×	2	95
Martin Russell United Kingdom	7	69 0.5×	26 0.4×	13 0.4×	32 1.2×	31 2.2×	9	112
Kathleen Nguyen United States	9	140 1.1×	111 1.7×	19 0.5×	34 1.3×	11 0.8×	24	185
Noura Radwan United States	6	119 0.9×	58 0.9×	27 0.8×	25 0.9×	17 1.2×	17	137
N. Antoniou Greece	7	66 0.5×	12 0.2×	13 0.4×	32 1.2×	20 1.4×	15	125
Elise De Bleser Belgium	10	179 1.4×	63 1.0×	29 0.8×	22 0.8×	45 3.2×	17	234
Jindong Dai China	9	117 0.9×	14 0.2×	55 1.5×	44 1.6×	29 2.1×	35	191
Isabelle Rieger France	4	68 0.5×	33 0.5×	17 0.5×	26 1.0×	22 1.6×	7	96

Countries citing papers authored by Alex Hoyle

Since Specialization

Citations

This map shows the geographic impact of Alex Hoyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Hoyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Hoyle more than expected).

Fields of papers citing papers by Alex Hoyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Hoyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Hoyle. The network helps show where Alex Hoyle may publish in the future.

Co-authorship network of co-authors of Alex Hoyle

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Hoyle. A scholar is included among the top collaborators of Alex Hoyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Hoyle. Alex Hoyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Haran, Áine, Thomas Hambrock, Alex Hoyle, et al.. (2022). 1359MO Differential treatment response with nodal metastases in metastatic hormone-sensitive prostate cancer (mHSPC) and evaluation of nodal (N) burden as a prognostic biomarker: Ancillary studies of the docetaxel and abiraterone acetate and prednisolone (AAP) phase III trials from STAMPEDE. Annals of Oncology. 33. S1161–S1162. 1 indexed citations

Brawley, Chris, J. Proudfoot, Alex Hoyle, et al.. (2022). 1358O Clinical qualification of transcriptome signatures for advanced prostate cancer (APC) starting androgen deprivation therapy (ADT) with or without abiraterone acetate and prednisolone (AAP): An ancillary study of the STAMPEDE AAP trial. Annals of Oncology. 33. S1161–S1161. 3 indexed citations

Ali, Adnan, Alex Hoyle, Áine Haran, et al.. (2021). Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer. JAMA Oncology. 7(4). 555–555. 74 indexed citations

James, Nicholas D., Hannah Rush, Noel W. Clarke, et al.. (2020). 611O Abiraterone acetate plus prednisolone for hormone-naïve prostate cancer (PCa): Long-term results from metastatic (M1) patients in the STAMPEDE randomised trial (NCT00268476). Annals of Oncology. 31. S509–S509. 14 indexed citations

Haran, Áine, Adnan Ali, Alex Hoyle, et al.. (2020). 634P Impact of metastatic lymph node burden on survival in patients with mHSPC from the "docetaxel comparison” of the STAMPEDE trial. Annals of Oncology. 31. S522–S523. 2 indexed citations

Ali, Adnan, Alex Hoyle, Christopher Parker, et al.. (2020). The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE’s “M1|RT Comparison”. European Urology Oncology. 3(4). 412–419. 11 indexed citations

Ali, Sumia, Alex Hoyle, Nicholas D. James, et al.. (2019). Benefit of prostate radiotherapy for patients with lymph node only or < 4 bone metastasis and no visceral metastases: Exploratory analyses of metastatic site and number in the STAMPEDE “M1|RT comparison”. Annals of Oncology. 30. v330–v330. 6 indexed citations

Akram, Ali, Fiona C. Ingleby, Alex Hoyle, et al.. (2019). Docetaxel for hormone-naïve prostate cancer: Results from long-term follow-up of metastatic (M1) patients in the STAMPEDE randomised trial (NCT00268476) and sub-group analysis by metastatic burden. Annals of Oncology. 30. v325–v326. 4 indexed citations

Hoyle, Alex, Sumia Ali, Nicholas D. James, et al.. (2018). Effects of abiraterone acetate plus prednisone/prednisolone in high and low risk metastatic hormone sensitive prostate cancer. Annals of Oncology. 29. viii722–viii722. 17 indexed citations

10.

Ali, Adnan, Alex Hoyle, Hitesh Mistry, & Noel W. Clarke. (2018). Importance of non‐regional lymph nodes in assigning risk in primary metastatic prostate cancer. British Journal of Urology. 123(1). 65–73. 11 indexed citations

11.

Clarke, Noel W., Adnan Ali, Hitesh Mistry, & Alex Hoyle. (2018). The importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.. Journal of Clinical Oncology. 36(6_suppl). 227–227. 1 indexed citations

12.

Hoyle, Alex, et al.. (2016). Surgical Management of Stuttering Ischemic Priapism: A Case Report and Concise Clinical Review. Urology Case Reports. 5. 22–24. 1 indexed citations

13.

Clarke, Noel W. & Alex Hoyle. (2016). The management of testis cancer. Surgery (Oxford). 34(10). 517–526. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact